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Abstract
Background: Udder infections with environmental pathogens like Escherichia coli are a serious problem for the dairy
industry. Reduction of incidence and severity of mastitis is desirable and mild priming of the immune system either
through vaccination or with low doses of immune stimulants such as lipopolysaccharide LPS was previously found to
dampen detrimental effects of a subsequent infection. Monocytes/macrophages are known to develop tolerance
towards the endotoxin LPS (endotoxin tolerance, ET) as adaptation strategy to prevent exuberant inflammation.
We have recently observed that infusion of 1 μg of LPS into the quarter of an udder effectively protected for
several days against an experimentally elicited mastitis. We have modelled this process in primary cultures of
mammary epithelial cells (MEC) from the cow. MEC are by far the most abundant cells in the healthy udder
coming into contact with invading pathogens and little is known about their role in establishing ET.
Results: We primed primary MEC cultures for 12 h with LPS (100 ng/ml) and stimulated three cultures either 12 h
or 42 h later with 10
7/ml particles of heat inactivated E. coli bacteria for six hours. Priming-related alterations in the
global transcriptome of those cells were quantified with Affymetrix microarrays. LPS priming alone caused
differential expression of 40 genes and mediated significantly different response to a subsequent E. coli challenge
of 226 genes. Expression of 38 genes was enhanced while that of 188 was decreased. Higher expressed were anti-
microbial factors (b-defensin LAP, SLPI), cell and tissue protecting factors (DAF, MUC1, TGM1, TGM3) as well as
mediators of the sentinel function of MEC (CCL5, CXCL8). Dampened was the expression of potentially harmful pro-
inflammatory master cytokines (IL1B, IL6, TNF-a) and immune effectors (NOS2, matrix metalloproteases). Functional
network analysis highlighted the reduced expression of IL1B and of IRF7 as key to this modulation.
Conclusion: LPS-primed MEC are fitter to repel pathogens and better protected against misguided attacks of the
immune response. Attenuated is the exuberant expression of factors potentially promoting immunopathological
processes. MEC therefore recapitulate many aspects of ET known so far from professional immune cells.
Background
Inflammation of the mammary gland (mastitis) caused
by environmental pathogens is a serious problem in
dairy industry. Infection with Escherichia coli (E. coli)
often provokes severe inflammation, greatly reduces
milk yield and may eventually cause heavy tissue
damage in the mammary gland [1,2]. Various attempts
were made in the past to reduce both, incidence and
severity of mastitis. These included measures promoting
effective pathogen clearance and preventing an exuber-
ant pathological inflammatory reaction. Prophylactic
immunization of cows with E. coli J5 bacterin as a vac-
cine consistently reduced the severity of the disease
[3,4]. However, it emerged during the last years that
such vaccinations do not reduce the rate of new
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response of the udder was primed by initiation of an
inflammation. Therefore, the udder was infused with
non-pathogenic bacteria [8] or the strong immune sti-
mulant lipopolysaccharide (LPS). This reduced the
severity of a subsequently elicited mastitis [9] and was
found to even protect shortly after endotoxin infusion
against an experimentally elicited mastitis [10]. The
mechanisms underpinning these potentially beneficial
effects are unknown.
A strong primary bacterial insult may cause reduced
immune responsiveness of the host to subsequent
pathogen challenges. This phenomenon known as
endotoxin tolerance (ET) was widely examined in vivo
in mouse and human during sepsis. Monocytes and
macrophages from those species have been used to
study relevant mechanisms in vitro [11,12] (see [13]
for a review). Endotoxin tolerant monocytes exhibit
decreased inducibility of pro-inflammatory cytokine
synthesis coupled with an upregulated synthesis of
anti-inflammatory cytokinesa sw e l la si n c r e a s e dp h a -
gocytosis [14]. These features contribute to protect
against septic shock and promote efficient bacterial
clearance in the case of a re-infection. On the other
hand, ET impairs antigen presentation of these cells
through strong and long-lasting reduced expression of
several major histocompatibility complex class II mole-
cules (MHC II) [14,15]. Impairment of TLR-signalling
by the induction of negative regulators, plasticity in
the dimer composition of the transcription factor NF-
B [12] as well as epigenetic chromatin modification at
promoters of different immune relevant genes contri-
bute to the phenotype of endotoxin-tolerance in
monocytes/macrophages [11]. Little is known about
the impact of other cell types for establishing the ET
phenotype.
Epithelial cells form the first line of defence against
invading pathogens. The mammary epithelial cells
(MEC) line the large surface area of the highly branched
milk parenchyma of the mammary gland. MEC outnum-
ber by far any other cell type possibly coming into con-
tact with pathogens invading the lactating mammary
gland. These cells are not only producing the milk but
contribute significantly to the immune defence of the
mammary gland [16,17]. They exert sentinel as well as
effector functions of immune defence. Pathogen contact
or stimulation with LPS endotoxin may elicit the expres-
sion of a battery of cytokines/chemokines and also of
factors directly fighting off pathogens. These include the
bactericidal b-defensins (lingual antimicrobial peptide
LAP, bovine neutrophil b-defensin BNBD5) [18,19],
some complement factors, and acute phase proteins
[16,17,20-22] collectively referred to as “effectors” of
innate immune defence.
Our group has recently found that a mild transient sti-
mulation of healthy udders with a single low dose of
LPS (1 μg/quarter) will not only reduce the severity of a
subsequently elicited E. coli mastitis, but will protect the
udder from colonization with E. coli pathogens for three
to ten days [23]. In order to analyze mechanisms of
inducible immune-protection in the udder, we used pri-
mary bovine MEC (pbMEC) as an established cell
model for monitoring udder relevant immune functions
[17]. Cultures were primed with low-doses of LPS and
changes in their global transcriptome were measured
with microarrays. Of particular interest was the evalua-
tion of LPS priming-related alteration of the MEC
response towards a subsequent challenge with E. coli.
We show that LPS priming enhances expression of bac-
tericidal and cell protective factors but attenuates patho-
gen induced expression of pro-inflammatory cytokines.
Results
Profiling the LPS-mediated modulation of the global
transcriptome in MEC
Cultures of primary epithelial cells (pbMEC) were used
to globally profile the effects of LPS on the transcrip-
tome. The cells were stimulated (primed) for 12 h with
a low concentration of LPS (100 ng/ml) and their RNA
was collected after either a short (18 h) or an extended
(48 h) waiting period (Figure 1). Respective controls of
untreated cultures were included. For monitoring the
effect of LPS priming upon the immune responsiveness
of those cells, we challenged the cultures for 6 h with
10
7/ml of E. coli particles either 12 h or 42 h after the
LPS pre-treatment. Thus, cells were either harvested 30
h (short waiting experiment) or 60 h (long waiting
experiment) after start. Adequate control cultures of
non-primed cells challenged with the same E. coli stimu-
lus were also analysed. The entire experiment therefore
consisted of eight different conditions. It was replicated
with pbMEC cultures obtained from three different
cows. Thus in all 24 RNA samples were collected and
individually analysed with GeneChip bovine genome
arrays (Affymetrix).
LPS priming induced changes level off after time
The correlation analysis of the microarrays (Figure 2)
revealed that the three biological replicates clearly clus-
tered together in any of the respective treatment groups
if the cells were collected 18 h after the LPS treatment.
This was no longer observed if the cells were analysed
after extending the waiting period to 48 h post priming.
Hence, the LPS effect vanishes with time.
In the short waiting experiments we found that prim-
ing modulated the abundance of 48 transcripts (37
higher and 11 lower; Table 1) relative to the control.
The expression of 317 transcripts was significantly
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quent to an E. coli challenge. Priming increased the
expression from 45 of these transcripts while decreasing
it from 272 of them (table 1; I.p.P. vs. I.). It was possible
to identify from these 317 differentially expressed tran-
scripts (DET) 226 differentially expressed annotated
genes (DEG; Table 1).
Challenging the cultures 48 h post-LPS-priming
modulated the abundance of only 15 DET including 13
DEG compared to the controls. Considering the modu-
lation of the immune responsiveness through LPS prim-
ing we found that this treatment regulated only six
genes differently, if the E. coli challenge was applied 48
h after the end of the LPS priming (Table 1). Therefore,
we focused our analysis on data obtained from the short
waiting experiments. We identified the human orthologs
of those bovine DEGs and only considered the human
identifiers for the subsequent analyses, since more com-
prehensive knowledge is available about the human fac-
tors regarding their functions and regulatory
relationships.
A complete list of significantly regulated genes and all
statistically relevant parameters is given in the Addi-
tional material (Additional file 1, Table S1 for the com-
parisons primed vs. control and Additional file 2, Table
S2 for induced post priming vs. induced).
Priming of pbMEC induced the expression of genes
involved in immune-protective mechanisms
Priming alone enhanced the expression of 30 genes in
pbMEC. The functional analysis of these genes with the
Ingenuity pathway analysis software (IPA) attributed to
them the category “Inflammatory Response” (including
10 factors, p = 9.53 × 10
-7) with highest statistical signif-
icance. Priming most strongly enhanced the abundance
of the mRNA encoding the chemokine CCL5 (466-fold,
Table 2). This factor recruits monocytes, T cells and
eosinophils but is also known to be anti-apoptotic for
macrophages. Priming also strongly enhanced the
expression of the acute phase response factors serum
amyloid A3 (SAA3), haptoglobin (HP), complement fac-
tor B (CFB), lactotransferrin (LTF), and of the
12 h
P:
Priming 100 ng/ml LPS1303
C:
Control
0 h
I:
Induction 107/ml E. coli1303
I.p.P.:
Induction post Priming 100 ng/ml LPS1303 107/ml E. coli1303
12 h 12 h or 42 h 6 h
Time line:
24 h or 54 h
Cell harvest
30 h or 60 h
priming Period: challenge waiting
Figure 1 Schematic diagram of the experimental setting.
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Figure 2 Dendrogram clustering the data from the individual
experimental cultures, using centred correlation and average
linkage. Numbers indicate pbMEC preparations obtained from the
three different cows. The dendrogram is based on all data as
obtained after the GCRMA normalization. Note that the data are
clustering according to treatment rather than the individuals from
which the pbMEC cultures have been established.
Table 1 Total numbers of significantly differentially
expressed transcripts (DET) and genes (DEG) comparing
LPS-primed (P.) vs. unstimulated pbMEC (C.) and E. coli
challenged primed (I.p.P.) vs. E. coli challenged naïve
cells (I.)
Short waiting period Long waiting period
P. vs. C. I.p.P. vs.I . P .vs. C. I.p.P. vs.I .
DET 48 317 15 6
↑ 37 ↓ 11 ↑ 45 ↓ 272 ↑ 11 ↓ 4 ↑ 2 ↓ 4
IPA mapped DEG 40 226 13 6
↑ 30 ↓ 10 ↑ 38 ↓ 188 ↑ 9 ↓ 4 ↑ 2 ↓ 4
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Page 3 of 13membrane protection factor mucin 1 (MUC1). More-
over, priming increased the mRNA abundance of a
whole battery of factors known to be involved in antigen
processing (leukocyte-derived arginine aminopeptidase,
ERAP2; cathepsin S, CTTS) and presentation (MHC
orthologs of HLA-DRA, HLA-DQA1, HLA-DQB1, HLA-
DMB, HLA-A, HLA-DMA; Table 2 and Additional file 1,
Table S1A).
Priming decreased the expression of only ten genes.
Overall, the magnitude of downregulation was very low.
The mRNA concentration of the most downregulated
gene ELTD1 (EGF, latrophilin and seven transmembrane
domain containing 1) was in primed cultures only 2/3
rd
of that found in the control cells (Table 2). This gene
encodes a G-protein coupled receptor with unknown
function. Three other downregulated genes are known
to increase “Apoptosis of Cell Lines” (tribbles homolog
3, Ras association domain family 4, and putative lym-
phocyte G0/G1 switch gene 2; Table 2).
Only nine genes were found to be differentially
expressed relative to the control if the waiting period
after the LPS stimulus was extended to 48 h. Priming
enhanced their expression. Three of those genes were
also found to be regulated after the short waiting period.
The latter genes encode CCL5, LTF, and transglutami-
nase 3 (TGM3). The extent of priming-induced
upregulation of CCL5 and LTF expression was weaker
in the long waiting experiment (36- and 2-fold, respec-
tively; Additional file 1, Table S1B). However, it was
stronger for TGM3 (7-fold after long- and 2-fold after
short waiting period; Additional file 1, Table S1B). The
mRNAs encoding interleukin IL-6 and the chemokine
CXCL6 were upregulated by priming only after the long
waiting period (6- and 4-fold; Additional file 1, Table
S1B).
Priming enhanced the E. coli mediated induction of
immune-protective molecules, but decreased expression
of pro-inflammatory and cell death associated factors
We have previously reported that an E. coli challenge of
naïve pbMEC regulated the expression of > 300 genes
[22]. Given this background knowledge, we analyse in
this study only the LPS priming-mediated modulation of
the E. coli-elicited response.
We observed for 226 genes a priming related modula-
tion of their expression subsequent to an E. coli chal-
l e n g e( T a b l e1 ;c o l u m n sI . p . P .vs.I . ) .E x p r e s s i o no f3 8
genes was higher while that of 188 genes was lower
than in non-primed but challenged cells (Figure 3A).
We first quantitatively differentiate the impact of the
LPS priming upon their subsequent regulation by the E.
coli challenge. The biological functions of the factors
Table 2 Top ten DEG after short waiting period comparing LPS-primed (P.) versus unstimulated control cells (C.)
Symbol Entrez Gene Name Mean ratio Expression regulated by*
P./C. IL1 TNF IL6 IRF7
Priming enhances expression of:
CCL5 chemokine (C-C motif) ligand 5 466 xxxx
SAA3 serum amyloid A3 146 x
FAM14A family with sequence similarity 14, member A 21
HP haptoglobin 14 xxx
RTP4 receptor (chemosensory) transporter protein 4 13
PARM1 prostate androgen-regulated mucin-like protein 1 8
CFB complement factor B 7 x
PLAC8 placenta-specific 8 7
HLA-DRA major histocompatibility complex, class II, DR alpha 6 x
MUC1 mucin 1, cell surface associated 5 xx
Priming decreases expression of:
ELTD1 EGF, latrophilin and seven transmembrane domain containing 1 -3.5
TRIB3 tribbles homolog 3 -2.1
TBXAS1 thromboxane A synthase 1 -2.0
RASSF4 Ras association domain family 4 -2.0
PYCR1 pyrroline-5-carboxylate reductase 1 -1.9
G0S2 putative lymphocyte G0/G1 switch gene -1.9 xx
FUT1 fucosyltransferase 1 -1.8
C1orf24 chromosome 1 open reading frame 24 -1.8
PCTP phosphatidylcholine transfer protein -1.6
PSAT1 phosphoserine aminotransferase 1 -1.6
* Expression of the respective gene is known to be regulated by IL1, TNF, IL6, and/or IRF7 (based on Ingenuity Knowledge Database).
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Page 4 of 13encoded by the DEG were determined using the Ingenu-
ity software. In a second step we identified the molecu-
lar relationships of all 226 DEG by an IPA network
analysis.
The LPS priming mediated quantitative modulation of
mRNA levels eventually affects all different regulatory
levels controlling mRNA abundance. Accordingly, we
sort the genes into six different regulatory groups.
Priming enhanced expression after E. coli challenge
We first consider those 38 genes revealing increased
mRNA abundance after an E. coli challenge compared
to non-primed cells.
Group1: Priming enhanced induction after an E. coli
challenge Sixteen of these 38 genes revealed higher
mRNA concentrations than observed in unstimulated
control cells (Additional file 2, Table S2A, highlighted in
red). Most of them (11 genes) were already induced by
priming only (Figure 3A; Table 3 compare columns I.p.P./
C. vs. P./C.; Additional file 2, Table S2A). Examples
include CORO1A (coronin, actin binding protein, 1A),
CD55 (decay accelerating factor for complement; also
known as DAF), SLPI (secretory leukocyte peptidase inhi-
bitor), and all three MHC II-encoding factors (orthologs
of the human factors HLA-DRA, HLA-DQA1, HLA-
DQB1). The E. coli stimulus did not increase their mRNA
abundance any further. However, it did increase the
mRNA concentration of the bactericidal b-defensins
(DEFB4, human ortholog of the bovine b-defensins, nota-
bly the lingual antimicrobial peptide [LAP]) and those
membrane protection factors TGM3 (transglutaminase 3)
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Figure 3 Overview of differentially expressed genes in primed and challenged pbMEC (I.p.P.) compared to naïve cells challenged with
the same E. coli stimuli (I.). A: Hierarchical clustering of the 226 DEGs comparing primed and challenged cells to naïve challenged pbMEC. The
heat map represents the expression level of each DEG in the three different pbMEC preparations (1, 2, 3) as determined in the three challenge
groups (I.p.P., I., and P.). Data were sorted according to the extent of the differential expression between I.p.P. vs. I. The heatmap is based on the
log(2) fold changes between the 3 treatment groups relative to the respective un-stimulated control cells (Additional file 2, Table S2A). The rows
of the matrix were normalized to have the values 0 as a mean, and 1 as associated variance. Red indicates high and green low expression. B:
IPA network analysis of the regulatory relationship of DEGs between the treatment groups I.p.P. (induction post priming) vs I. (challenge of naïve
cells). Red, higher expression in I.p.P.; green, lower expression in I.p.P. IL-1B is known to regulate the expression of 44 genes (red arrows). The
transcription factor IRF7 is known to regulate the expression of 34 genes (blue arrows).
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Page 5 of 13and MUC1 (mucin 1) above their already priming-induced
increased levels. Interestingly, mRNA levels of two genes
with an enhanced expression in primed and E. coli chal-
lenged cells (CORO1A, CD55)w e r ed e c r e a s e db ya nE. coli
challenge of non-primed cells.
Group 2: Priming prevented pathogen mediated
downregulation Eighteen genes revealed significantly
higher mRNA concentrations in primed and E. coli chal-
lenged (I.p.P.) than in non-primed challenged cells (I.)
although their mRNA concentrations were not changed
compared to the unstimulated controls (Table 3; Addi-
tional file 2, Table S2A, highlighted in grey). This indi-
cates that priming prevented their downregulation in
response to an E. coli challenge. The identification of
their associated biological functions by IPA analysis
revealed that three of those factors are associated with
“Molecular Transport” (solute carrier family 34, member
2, ATPase, H+ transporting, lysosomal V0 subunit a iso-
form 4, and sodium channel, nonvoltage-gated 1 alpha;
p = 6.29 × 10
-3) and two factors are involved in “Pyrimi-
dine” as well as “Purine Metabolism” (CRCP, Calcitonin
gene-related peptide receptor component and POLRMT,
polymerase [RNA] mitochondrial [DNA directed]).
Group 3: Priming reduced pathogen mediated down-
regulation The mRNA abundances of four genes were
higher in primed and challenged cells compared to non-
primed challenged cells because their E. coli induced
downregulation was diminished by priming (Additional
file 2, Table S2A, highlighted in green). These encode
the transcription factor CP2-like 1, the heat shock pro-
tein HSPB6, the ribosomal modification protein
RIMKLB, and the sclerostin domain containing 1. Down
regulation of the latter factor in breast ductal epithelial
cells is associated with breast cancer [24].
Priming provoked a significant lower induction after the E.
coli challenge
Overall, we found 188 genes with a significantly lower
mRNA abundance in response to the E. coli stimulus
after the short waiting period post-priming.
Group 4: Priming prevented pathogen mediated
induction The expression of 30% of the 188 genes with
lower mRNA concentration in E. coli challenged primed
Table 3 Priming-related modulation of gene expression subsequent to an E. coli challenge after a short waiting period
Symbol Entrez Gene Name Mean ratio Mean ratio compared to
un-stimulated control
(C.)
Expression regulated
by****
I.p.P/I. I.p.P./C. I./C. P./C. IL1 TNF IL6 IRF7
Priming provokes a higher the expression level after an E. coli challenge of:
CORO1A* coronin, actin binding protein, 1A 2.8** 2*** -2 2
CD55 CD55 molecule, decay accelerating factor for complement 2.6 2- 2 2 xx
HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 2.3 42 4 x
TGM3 transglutaminase 3 2.3 4 2 2
SLPI secretory leukocyte peptidase inhibitor 2.2 52 4 x
LY6G6E lymphocyte antigen 6 complex, locus G6E 2.2 2 NC 2
CYP26A1 cytochrome P450, family 26, subfamily A, polypeptide 1 2.1 NC -2 2
DEFB4A defensin, beta 4A 2.1 47 22 24 xx
HLA-DRA major histocompatibility complex, class II, DR alpha 2.1 63 6 x
ATP6V0A4 ATPase, H+ transporting, lysosomal V0 subunit a4 2.0 NC -2 NC
Priming provokes a lower expression level after an E. coli challenge of:
NOS2 nitric oxide synthase 2, inducible -10.7 14 154 N C xxx
GBP2 guanylate binding protein 2, interferon-inducible -8.1 36 287 10 xxx
APOL3 apolipoprotein L, 3 -7.9 4 30 NC
IL1B interleukin 1, beta -6.4 5 32 NC x x
TIFA TRAF-interacting protein with forkhead-associated domain -6.0 6 36 NC
TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b -5.8 15 89 NC x x
TMEM140 transmembrane protein 140 -5.8 2 11 NC
GBP4 guanylate binding protein 4 -5.8 NC 6 NC x x
LMO2 LIM domain only 2 (rhombotin-like 1) -5.3 NC 5 NC
RTP4 receptor (chemosensory) transporter protein 4 -4.7 15 72 4 x
* bold letters, part of a network connected by the IPA relationship “Expression” (Fig 3B)
** bold numbers, fc > 1.5, p < 0.005
*** italic number, fc > 1.5, p > 0.005
NC, No change fc < 1.5
**** Expression of the respective gene is known to be regulated by IL1, TNF, IL6, and/or IRF7 (based on Ingenuity Knowledge Database).
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Page 6 of 13cells compared to non-primed challenged cells (58
genes; Figure 3A; Additional file 2, Table S2A, high-
lighted in grey) was unchanged compared to the control
indicating that priming completely prevented their
induction. Fifteen of those genes are associated with the
functional category “Inflammatory Disease” (p = 3.71 ×
10
-4) and nine with “Cell Death” (p = 5.7 × 10
-4). Promi-
nent members of these categories are interleukin IL15,
toll-like receptor 3 (TLR3), the bovine ortholog of the
MHC I factor HLA-L, the death-domain associated pro-
tein DAXX, and the MHC II transactivator CIITA.
Group 5: Priming reduced the pathogen mediated
induction The induction of 106 genes was reduced but
not abolished by priming (Additional file 2, Table S2A,
highlighted in red). Twenty eight of those genes are
associated with the IPA category “Cell Death” forming
the category with the highest statistical significance (p =
4.56 × 10
-8). This category comprises molecules acting
downstream of the death receptors (e.g. the caspases
CASP4 and CASP7, the CASP8, FADD-like apoptosis
regulator CFLAR, and the baculoviral IAP repeat-con-
taining factors BIRC2 and BIRC3). The inducible nitric
oxide synthase NOS2 belongs to this group, representing
a candidate gene for bactericidal functions, but also the
similarly regulated genes encoding the pro-inflammatory
cytokine IL-1B and encoding the cytokines of the TNF-
ligand family (TNFSF13B and TNFSF10). LPS priming-
mediated attenuation of their pathogen-mediated induc-
tion suggests a general dampening of the inflammatory
response. Augmenting this we note that the level of the
mRNA encoding the TRAF interacting protein with
fork-head-associated domain (TIFA) is also greatly
reduced. This factor is an adaptor to the TNF receptor
associated factor 6 (TRAF6) as well as to the IL-1 recep-
tor-associated kinase 1 (IRAK1), both known as crucial
mediators of TLR-receptor driven NF-B activation
[25]. Thus, LPS priming dampens the pathogen-
mediated activation of this signalling cascade known as
a key regulator of inflammation.
Group 6: Priming enhanced pathogen mediated
downregulation Priming prior to the E. coli stimulation
enforced the downregulation of 24 genes (Additional file
2, Table S2A, highlighted in green). Seven of them are
associated with the IPA category “Cell Death” (p = 1.82
×1 0
-3), including epidermal arachidonate lipoxygenase
ALOX12, the insulin-like growth factor binding protein
IGFBP5,a n dt h ep s e u d o k i n a s eTRIB3. The latter factor
may promote cell death but is also known to inhibit
lipid metabolism and insulin-mediated activation of the
protein kinase AKT.
E. coli challenge after long time priming
Challenging the cells 42 h after the LPS priming with E.
coli greatly reduced the LPS effect upon the pathogen
response. We found only six genes significantly
differentially expressed between the induction post
priming and the induction without priming (Table 1;
Additional file 2, Table S2B). Two genes revealed a
higher and four a lower expression. Their relevance for
immune functions has not been reported.
Identification of central factors regulating the different
response to E. coli after priming
The expression related interdependence of those 226
priming mediated DEGs was analysed with the IPA soft-
ware in order to uncover regulatory key factors. A net-
work emerged comprising 78 of those DEGs. It is
associated with the IPA functions “Inflammatory
Response”, “Antimicrobial Response”, and “Inflammatory
Disease” (Figure 3B). The central node molecules in this
network are the cytokine IL-1B and the transcription
factor interferon regulatory factor 7 (IRF7). IL-1B is
known as a central regulator of immune response and
the IPA data base indicates that it may affect the expres-
sion of 44 from among our 226 DEGs, including IRF7.
This factor is activated through the TRIF-factor depen-
dent downstream signalling of TLR4 and of the endoso-
mal TLR receptors (TLR3, 7, 8, 9) [26]. IRF7 is known
to directly influence the expression of 34 DEGs. Other
factors occupying node posit i o n si nt h i sn e t w o r ka r e
known as DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
(DDX58; linked to 14 downstream factors), IRF1 (linked
to 13 downstream factors), and TNFSF10 (linked to 12
downstream factors). The expression levels of all these
factors were reduced by the LPS priming prior to the
pathogen challenge.
Validation of the induction post-priming experiment by
RT-qPCR
Our microarray analysis had shown that priming prior
to a pathogen challenge enhances the expression of bac-
tericidal and immune-protective factors while attenuat-
ing cytokine and chemokine expression. We used RT-
qPCR to validate from the same RNA samples as used
for the microarray analysis the differential expression of
representative candidate genes (Figure 4; Additional file
3, Table S3 and Additional file 4, Table S4). We
included some other key immune regulatory factors
(TNF-a, IL6, CXCL8 [also known as IL8]) factors reveal-
ing a statistically insignificant modulation in the micro-
array experiments under the stringent conditions
applied to that analysis. We found a good correlation (r,
0.91; 14 genes) between changes measured by RT-qPCR
and the microarray data (Additional file 5, Table S5).
The RT-qPCR data show that priming quenched the
pathogen induced expression of the cytokines IL1B,
TNF-a, and IL6 by ~30-50%. The mRNA concentrations
of these factors are known to eventually peak in MEC
within 1 h after an E. coli stimulation and are
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Page 7 of 13subsequently massively downregulated to lower levels
which are sustained from 6 h to 24 h post stimulation
[22,27]. Thus, the only moderate modulation after 6 h
of pathogen stimulation as observed here is conceivably
ac o n s e r v a t i v ee s t i m a t eo ft h ea c t u a lp r i m i n g - r e l a t e d
changes.
IL-1B, TNF-a, and IL-6 are often called “master” cyto-
kines, owing to their secretion and perception by many
different cell types and their key role in orchestrating
the synthesis of other cytokines and chemokines. TNF-a
may eventually influence the expression of 60 of those
226 priming-mediated DEGs while IL-6 might affect the
expression of another 27 DEGs (Table 3; Additional file
1, Table S1 and Additional file 2, Table S2). Similarly
reduced was the IL-1/IRF7 regulated induction of the
factors NOS2 (bactericidal and immune regulatory),
IL15, MX2, and RTP4. On the other hand, the RT-qPCR
measurements very clearly confirmed that priming alone
significantly enhances the expression of the key
chemokines (CCL5, IL8), of anti-microbial factors (LAP,
SLPI) and also of molecules which are known to pro-
mote cell and tissue protection in the course of an
inflammation (S L P I ,T G M 3 ,S A A 3 ,L T F ). The priming-
mediated enhanced expression of LAP, SLPI, and TGM3
after pathogen stimulation was also confirmed.
Discussion
Priming of udders with LPS protects for a limited time
against manifestation of experimentally induced mastitis
in mid-lactating cows [10,23]. Mild endotoxin stimula-
tion might thus possibly be developed as a means to
reduce both, incidence and severity of mastitis in critical
periods of the lactation cycle. We have undertaken the
current study to learn more about the broader implica-
tions of a mild endotoxin pre-stimulation (priming) of
primary MEC cultures upon their subsequent reaction
towards a challenge with heat inactivated E. coli parti-
cles. We have previously reported on relevance and






[
IL6

-1.5



IL1B






[
-2.0


TNF-D





[
-1.6


NOS2







[
-3.4



RTP4




[
6.4



-2.3




MX2





[
5.7



-4.1



IL15





[
-2.2



 
3URLQIODPPDWRU\PDVWHUF\WRNLQHV (IIHFWRUVGULYHQE\,/%DQGRU,5)
LAP





[
8.7




1.6



SLPI







[
2.4



1.7









[
22.0



CCL5 IL8




[
2.5




TGM3









[
2.2



2.1




SAA3




[
77.4




LTF






[
3.9



&KHPRNLQHV $QWLPLFURELDO &HOODQGWLVVXHSURWHFWLRQ
P
5
1
$

>
U
H
O
D
W
L
Y
H

F
R
S
\

Q
X
P
E
H
U
@
Figure 4 Quantification of the expression of selected genes by RT-qPCR. Ordinate, relative copy number (n, 3 each; ± S.E.M.) determined in
the short time waiting experiment. Open bars: unstimulated control, filled bars: primed cells, light sanded bars: E. coli induction of naïve cells;
dark shaded bars: E. coli induction of primed cells. Fold changes and significance (* p < 0.1, ** p < 0.05, *** p < 0.01, paired t-test) of the
priming-related differential expression are indicated. All individual data are listed in the Additional file 4, Table S4.
Günther et al. BMC Genomics 2012, 13:17
http://www.biomedcentral.com/1471-2164/13/17
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related immune regulations, on the E. coli challenge as
also applied here and on the general techniques of our
microarray analysis [17,18,22,27,28]. We based the cur-
rent study on using primary MEC cultures from three
different cows. Using this small number of biological
replica might limit the statistical power. However, we
have previously documented that the intra-animal varia-
bility of pathogen induced gene expression between
those cultures is much less than observed between cows
[22]. We discuss our key observations in terms of prim-
ing (i) enforced sentinel functions of the MEC, (ii)
improved protection against pathogens and tissue
damage and (iii) reduced expression of master cytokines
and potentially harmful factors limiting the risk of
induced immune-pathology.
Priming enforces sentinel functions of the MEC
A mild LPS priming (1 μg/udder quarter, for 12 h) was
found to significantly increase in vivo the number of
somatic cells in udders [23]. Thus, it was not surprising
to find in our in vitro pbMEC model that LPS priming
enhanced quite strongly the level of mRNAs encoding
the chemokines CCL5 (also known as RANTES) and
CXCL8. Both factors are known to trigger diapedesis of
mononuclear cells, T-cells and macrophages (CCL5
[29]) and polymorph nuclear granulocytes (PMN;
CXCL8 [30]) through the endothelia of the blood vessels
recruiting them into the inflamed sites. Elevated levels
of both factors enhance the abundance of professional
sentinel cells (e.g. macrophages) in the udder and con-
c e i v a b l yi m p r o v et h ec o m p e t e n c eo ft h eg l a n dt oc o u n -
ter act recurrent infections. It is known from
macrophages that LPS priming enhances CCL5 expres-
sion in response to a second LPS stimulus [11].
In contrast to observations made on endotoxin toler-
ant macrophages [14,15], we found that priming
increased the abundances of a variety of mRNA moieties
encoding peptidases for antigen processing (ERAP2,
CTTS) and MHC-II factors (bovine orthologs of HLA-
DQA1, -DRA, -DQB1) in MEC. While MEC are gener-
ally not considered as professional antigen-presenting
cells (APCs) it is known that alveolar epithelial cells
express MHC-II factors and are relevant APCs in the
lung [31]. Thus, enhanced expression of these factors in
LPS-primed MEC suggests an improved readiness of the
primed cells for antigen presentation and thus improv-
ing their sentinel competence.
Priming improves protection against pathogens and
tissue damage
Priming increased the levels of mRNAs encoding the
bactericidal b-defensin lingual antimicrobial peptide
(LAP). It was shown in macrophages that ET remodels
the chromatin at the promoters of such “not LPS toler-
ant” effector genes of immune defence through differen-
tial histone modification making them more quickly
responsive to a second stimulus [11]. Epigenetic
mechanism might also operate during ET at the LAP
promoter of the MEC, since mastitis induced expression
of the LAP gene requires chromatin decompaction at
the promoter [32].
Focussing on LAP as an example for a b-defensin
encoding gene serves only as a paradigm for the regula-
tion of this class of molecules, which are so abundantly
encoded in the bovine genome. More than 100 highly
related copies of b-defensin-encoding genes were uncov-
ered in the analysis of the entire bovine genome [33].
The infection induced expression of LAP and other b-
defensins in the udder has previously been reported
[18,19,34]. The wealth of these b-defensin-encoding
genes could not be analysed with the tools applied in
this study, but LPS priming-enhanced abundance of the
LAP-encoding RNA might be indicative for the regula-
tion of other members of this gene family. Hence, LPS
priming supports protection against colonization of the
udder by bacterial pathogens. This was indeed found to
be the case in vivo [10,23].
Priming increased also the mRNA level of the defensin
like factor secretory leukocyte peptidase inhibitor (SLPI),
known as contributing to the defence against bacteria,
fungi and retroviruses in epithelial tissues [35]. This
multifunctional serine protease inhibitor protects epithe-
lial tissue during inflammation from the attack by endo-
genous proteolytic enzymes. Moreover, SLPI is known
to bind and synergize with proepithelin. This growth
factor promotes proliferation of epithelial cells and sup-
presses activation of neutrophils. SLPI abrogates proteo-
lytic cleavage of proepithelin into the inflammation
sustaining factor epithelin [36]. Lactotransferrin (LTF) is
another multifunctional factor revealing LPS priming-
related upregulated mRNA levels. This factor has bac-
teriostatic, bactericidal and some immune modulating
properties, but also the capability to bind LPS (reviewed
in [37]). It was shown that LTF pre-treatment protects
mice from pathophysiological effects of LPS and
enhances the survival after an LPS injection [38]. Prim-
ing enhanced the levels of the mRNA encoding the
complement factor CFB. This protein activates the alter-
native complement pathway thereby strengthening
unspecific immune defence mechanisms. Expression of
this factor in the udder is also strongly induced during
E. coli-elicited mastitis [17].
Priming increased the mRNA abundances of several
factors protecting against membrane damage associated
with the so called “bystander killing” effect of activated
immune defence. These include the decay accelerating
factor for complement CD55 (also known as DAF)
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guided attacks through complement factors and also the
glycoprotein mucin 1 (MUC1). This mucin is a key
component of the apical (luminal) membrane of the
MEC [39] forming a physical barrier against microbial
attacks [40]. Increased expression of the transglutami-
nases TGM1 and TGM3 indicates stabilization of tissues
and cells by protein cross-linking [41]. These factors
contribute also to the formation of tight junctions
between mammary epithelial cells and are known to
promote cross linking of proteins in the extracellular
matrix thereby initiating wound healing.
Priming reduces expression of master cytokines and of
potentially harmful factors
It is known from macrophages that endotoxin tolerance
(ET) down-regulates the expression of the inflammatory
master cytokines tumor necrosis factor a (TNF-a), inter-
leukin 1 (IL-1) and IL-6 (reviewed in [13]). They all belong
to the class of “LPS-tolerant” genes which become refrac-
tory in macrophages to repeated LPS stimulation [11]. We
now made a similar observation in the MEC. LPS priming
moderately, yet significantly reduces their mRNA levels
after a subsequent E. coli challenge in these cells. These
three factors together orchestrate and dominate many
aspects of the local as well as systemic immune response
[42,43]. While their adequate induction through invading
pathogens is indispensable for mounting a productive
immune defence in the host, their overshooting expression
m a yb ed e t r i m e n t a l .C o n f i n i ng their expression is there-
fore an overarching beneficial effect of ET and contributes
to prevent immune-pathology. Our data suggest that this
principle applies also to the regulation of the immune
defence in the udder mediated through MEC. Moreover,
we validated reduced and confined expression for some of
their secondary response factors during the subsequent
pathogen challenge. These factors include the nitric oxide
synthase NOS2. This enzyme produces nitric oxide radi-
cals, which are bactericidal but also harmful to the host
cells and tissues as well. Similarly, expression of the metal-
lopeptidases (MMP9, MMP13) was found to be confined
by LPS priming. These proteases may disintegrate the
extra-cellular matrix and connectives. LPS priming
appears to prohibit their exuberant production and thus
reduces activity of these potentially harmful factors.
Expression of many factors associated with cell death
was found to be limited by LPS priming. These factors
include the caspases CASP4 and -7, DAXX, CFLAR to
name only some of them. Reduced and limited induc-
tion of these factors is conceivably a consequence of
reduced TNF-a induction and indicates improved pre-
servation of cell- and tissue-integrity.
Reduced and dampened induction of the TLR/NF-B
axis of pathogen signal transduction appears to be
crucial for the ET mediated modulation of the immune
response in the MEC. Not only was the pathogen stimu-
lated expression of several TLRs reduced (TLR2,- 3,-4)
but also were factors induced by the LPS priming which
are known to interfere with NF-B activation, including
the coronin CORO1A and SPLI.C O R O 1 Ai sk n o w nt o
suppress TLR2, TLR3, TLR4 and TNF-a mediated NF-
B activation as well as IFN-b promoter activation [44].
Indeed, we found that the mRNA expression of various
type I interferon response factors was decreased by
priming (e.g. myxovirus resistance 2 [MX2], receptor
transporter protein 4 [RTP4], 2’-5’-oligoadenylate
synthetase 1 [OAS1], interferon stimulated exonuclease
gene 20 kDa [ISG20]). The factor SLPI has not only a
broad spectrum of antimicrobial activities but also anti-
inflammatory/immunomodulatory functions [45]. SLPI
interferes also with TLR-4 mediated NF-B activation
by inhibiting the interaction between CD14 and LPS
[46] thus quenching the production of inflammatory fac-
tors like TNF-a, NOS2, COX2, and MMPs [47,48].
Conclusions
Our global transcriptome assay shows that the MEC
recapitulates many aspects of LPS-induced ET which
were known so far only from macrophages/monocytes.
These features eventually protect the cow from detri-
mental effects of an overshooting immune response eli-
cited in that very large organ, the udder. Moreover,
analysis of our model cells revealed that LPS priming
enforces the production of anti-microbial factors, pro-
tects integrity of the epithelial cells through enforced
tissue stabilization and wound healing. Our data collec-
tively reveal mechanisms underpinning the observation
made in vivo that LPS pre-stimulation of the udder pro-
tects against E. coli elicited mastitis.
Methods
Cell culture
Primary cultures of MEC (pbMEC) were obtained from
udders of three healthy, pregnant (day 130 of gestation)
cows in the mid of their first lactation. Cell preparation
and their culture on collagen coated dishes were as pre-
viously described [17]. The pbMEC growth medium
(GM) was RPMI 1640 (Biochrom AG; Berlin, Germany)
supplemented with prolactin, hydrocortisone, insulin
and 10% FCS as described [18]. Fibroblasts were selec-
tively removed by repeated trypsinization. We number
throughout the cultures derived from those three indivi-
dual cows as 1, 2 or 3.
E. coli 1303 and LPS preparation
Heat killed (60°C, 30 min) particles of the mastitis caus-
ing E. coli strain 1303 [19] have been prepared as
described [17]. LPS was prepared from this strain by
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tography [49] followed by a purification with triethyla-
mine and deoxycholate [50] (kindly provided by Sonja
von Aulock, University of Konstanz, Germany). It was
dissolved in GM (1 mg/ml) by ultra-sonic dispersion (2
min) and aliquots were stored at -20°C.
LPS priming and challenge with heat inactivated E. coli
particles
Figure 1 illustrates the experimental settings. Each
experiment was performed in triplicate using separate
pbMEC cultures (80% confluence) prepared from the
udders of those three different cows. Controls (C.) were
cultured for 12 h in GM, washed 3× with PBS and culti-
vated for additional 18 h (short waiting experiment) or
48 h (long waiting experiment). For the priming experi-
ment (P.) the pbMEC cultures were stimulated
("primed”)a tt i m e0hw i t h1 0 0n g / m lL P S ,w a s h e d
three times with PBS and cultivated for another 18 h or
48 h. For the induction trial (I.) cells were challenged
with 10
7/ml particles of heat killed E. coli1303 for 6 h.
The cultures were handled exactly like the control
g r o u p( C . )p r i o rt ot h eE. coli challenge. For the induc-
tion post priming experiment (I.p.P.) cultures were
primed for 12 h with LPS, just as described for the
priming group (P.). After 3× washing with PBS and
waiting for 12 h or 42 h in GM the I.p.P. cultures were
also challenged with 10
7/ml particles of E. coli1303. Cells
were harvested at time 30 h (short waiting experiments)
or 60 h (long waiting experiments) and total RNA was
prepared.
Microarray hybridisation
Total RNA for the microarray analysis was extracted
with the RNeasy kit exactly as described by the manu-
facturer (Qiagen, Hilden, Germany). RNA processing,
labelling and hybridization used the respective reagent
kits from Affymetrix and was exactly done as previously
described [22]. Briefly, 5 μg total RNA of each sample
was used for cRNA preparation and labelling with the
Affymetrix GeneChip
® Expression 3’ Amplification One-
Cycle Target Labelling Kit (Affymetrix, St. Clara, USA).
The fragmented cRNA was hybridized for 16 hours at
45°C to GeneChip
® Bovine Genome (Affymetrix). The
Microarrays were scanned at 1.56 micron resolution
using the GeneChip Scanner 3000 7G (Affymetrix). The
microarray data sets were submitted to the Gene
Expression Omnibus (GEO) database (accession no.
GSE32186).
Microarray analysis
T h em i c r o a r r a yd a t aw e r ea n a l y s e du s i n gt h eB i o m e t r i c
Research Branch (BRB) array tools version 4.1 [http://
linus.nci.nih.gov/BRB-ArrayTools.html]. Background
correction and normalization of the expression values
was performed using the GC Robust Multi-array Aver-
age (GCRMA) algorithm [51]. Transcripts were defined
as significant differentially expressed (DET) among Con-
trol (C.) and Priming (P.) as well as among Induction
(I.) and Induction post Priming (I.p.P.) groups if their
fold change exceeded > 1.5 and the p-value of the uni-
variate t-test between values paired according the
pbMEC preparation was < 0.005. False discovery rates
(FDR) values were calculated and are listed in the addi-
tional files (Additional file 1, Table S1 and Additional
file 2, Table S2). However, this parameter was not
applied as a cut off criterion since it would have been
too stringent for some comparisons, resulting in no sig-
nificantly regulated genes at all. This applies in particu-
lar to the comparison between primed vs.c o n t r o l
cultures. Human orthologs of differentially expressed
genes (DEG) were determined as described previously
[22,52]. Gene ontology and network analysis was per-
formed using the Ingenuity Pathways Analysis (IPA 9.0)
software (Ingenuity Systems, Redwood City, CA). This
program identifies the biological functions that were
most significant to a data set using Fisher’se x a c tt e s t .
The calculated p-value specifies the probability that
each biological function assigned to a gene list is solely
due to chance. The heatmap was generated using the
software tool matrix2png [53].
Quantitative real-time PCR (RT-qPCR)
Total RNA extraction with Trizol (Invitrogen, Karlsruhe,
Germany), cDNA preparation with Superscript II (Invi-
trogen) and quantification of mRNA copy numbers with
the LightCycler instrument and the SYBR Green plus
reagent kit (both from Roche, Basel, Switzerland) was as
described [54]. Quality of the PCR products obtained in
those LightCycler runs was validated by subcloning the
amplicons into pGEM-Teasy (Promega) and sequencing.
Relative copy numbers were titrated against external
standards consisting ofad i l u t i o ns e r i e s( 1 0
6 to 10
copies) of those sequenced plasmids. Sequences of the
oligonucleotide primers used are given in Additional file
6, Table S6. Significance of differences was assessed
with the t-test of paired values. Spearman’s Rank Corre-
lation was used to compare microarray and RT-qPCR
measurements using the SigmaStat 3.5 software (Systat
Software Inc., San Jose, California, USA).
Additional material
Additional file 1: Table S1: All DEG from comparison Priming (P.)
versus Control (C.). A) Short time waiting experiment (40 IPA mapped
DEG). B) Long time waiting experiment (13 IPA mapped DEG)
Additional file 2: Table S2: All DEG from comparison Induction post
Priming (I.p.P.) versus Induction (I.). A) Short time waiting experiment
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Page 11 of 13(226 IPA mapped DEG). B) Long time waiting experiment (6 IPA mapped
DEG)
Additional file 3: Table S3: Comparison of RT-qPCR and microarray
measurements of selected candidate genes
Additional file 4: Table S4: All RT-qPCR values (relative mRNA copy
numbers) contributing to Figure 4.
Additional file 5: Table S5: Correlation of relative mRNA
concentrations determined in microarray hybridizations or RT-qPCR
from three biological pbMEC replica of the four challenge groups
(C., P., I., and I.p.P.) of the short and long waiting experiments
Additional file 6: Table S6: Sequences of oligonucleotide primers
used for real-time PCR quantification
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